ArticleCancer gene therapy2024

Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway.

Fengyan Yuan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.